About Medviso
Medviso is a healthcare AI company that develops advanced software solutions for quantitative medical image analysis, primarily focusing on cardiac MRI (CMR) and CT scans. Their mission is to integrate the latest research into clinical practice, providing tools that enhance clinical decision-making and improve patient care. The company’s core offerings include software for MR and CT image analysis, 3D modeling services, regulatory consulting, and medical software solutions like Segment and Segment 3DPrint.
For physicians, Medviso’s Segment CMR software offers AI-powered cardiovascular MR analysis, designed for confident clinical decision-making. It’s a vendor-independent solution for comprehensive analysis of CMR images, combining AI-powered automation with validated analysis tools to boost efficiency and maintain accuracy. Key features include AI-powered chamber segmentation, efficient and reproducible strain analysis, comprehensive tissue characterization (T1, T2, T2*, ECV), fully automatic viability analysis, integrated perfusion analysis, and 2D/4D flow analysis. The software also includes AI AutoMate, an automated processing pipeline that streamlines the entire CMR analysis process from raw DICOM data to fully analyzed results, reducing manual effort and potential for human error.
Medviso’s Segment 3DPrint is another significant tool, enabling the generation of 3D models for diagnostic purposes in orthopedic, maxillofacial, and cardiovascular applications. These models can be used for visualization, measurement, and treatment planning, and can also be used to fabricate physical replicas through additive manufacturing. The company emphasizes user-friendliness, accuracy, reproducibility, and excellent customer service, with their software bearing the CE-mark of conformity and FDA 510(k) clearance.
Focus Areas
Business Intelligence
| Technology | MATLAB, cloud-native (for image transfer in clinical trials) |
What Physicians Need to Know
Medviso's software, particularly 'Segment CMR', offers AI-powered automation for cardiac MRI analysis, which can significantly save time on contouring and processing. The unique cardiac strain analysis solution combines feature tracking and tagging, providing comprehensive insights into cardiac contraction dynamics. The FDA 510(k) and CE mark clearances for their clinical software ensure adherence to high standards of safety and efficacy. Physicians can benefit from the intuitive interface, flexible license terms, and strong customer support. The automated report generation also helps save time in clinical workflows. For surgical planning, 'Segment 3DPrint' allows for the creation of high-quality 3D anatomical models from DICOM images.
Medviso's software solutions, such as Segment CMR and Segment CT Research, offer PACS connectivity for efficient data import and integration into existing clinical workflows. Their custom development services also include expertise in DICOM competence, allowing for integration with various MR, CT, PET, and SPECT vendors. The complete software packages can include PACS integration, Report Generation Modules, and Patient Database Synchronization Modules.
What the Web Says
Medviso, a Swedish medical technology company, specializes in software for cardiovascular magnetic resonance (CMR) imaging post-processing, with its flagship product being Segment CMR. The software is widely used in research and clinical settings, with over 1300 peer-reviewed publications utilizing Segment solutions. While there is positive feedback regarding the software's capabilities, user-friendliness, and customer support, there appears to be significant confusion and negative sentiment on platforms like Reddit regarding a different company named "MedVi" which offers weight loss programs. It is crucial to distinguish between Medviso (medviso.com) and MedVi, as the latter has numerous complaints about scams, billing issues, and poor customer service.
Overall: MixedStrengths
- Exceptional software for CMR imaging post-processing.
- Versatile with various functionalities.
- Remarkable accuracy and reproducibility.
- Automated report generation saves time.
- Outstanding and fluent customer service and technical support.
- Constantly evolving with new features and optimized UI, including AI-based LV segmentation that decreases processing time.
Limitations
- Confusion with a different company named "MedVi" which has many negative reviews.
- Some users find the interface complex at first, requiring time to find features (referencing Medius, but could be a general software critique).
- Lack of clarity in online documentation (referencing Medius, but could be a general software critique).
- Cost of the Strain module (4000€ for a single license, 7000€ for a site license).
Based on reviews from: Medviso.com, Reddit, TrustRadius, G2, Capterra, Scintica.shop
Last updated: 2026-10-29
Videos
News, demos, and interviews about Medviso.
Videos load interactively. If none appear, search YouTube for Medviso →
Press & Coverage
Frequently Asked Questions
Comparisons
When choosing between D2P by 3D Systems and Segment 3DPrint by Medviso AB, physicians should consider their primary use case and existing infrastructure. Both tools excel at converting 2D medical imaging data (DICOM) into 3D digital anatomical models for advanced visualization and 3D printing, leveraging AI for segmentation. However, their key practical differences lie in […]
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]
